Inicio>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Eriocitrin

Eriocitrin (Synonyms: Eriodictioside, Eriodictyol 7-O-rutinoside)

Catalog No.GC38181

La eriocitrina es un flavonoide aislado del limÓn, que es un fuerte agente antioxidante. La eriocitrina podrÍa inhibir la proliferaciÓn de lÍneas celulares de carcinoma hepatocelular al detener el ciclo celular en la fase S a través de la regulaciÓn positiva de p53, ciclina A, ciclina D3 y CDK6. La eriocitrina desencadena la apoptosis al activar la vÍa de seÑalizaciÓn intrÍnseca involucrada en las mitocondrias.

Products are for research use only. Not for human use. We do not sell to patients.

Eriocitrin Chemical Structure

Cas No.: 13463-28-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
74,00 $
Disponible
1mg
35,00 $
Disponible
5mg
56,00 $
Disponible
10mg
98,00 $
Disponible
20mg
161,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Eriocitrin is a flavonoid isolated from lemon, which is a strong antioxidant agent. Eriocitrin could inhibit the proliferation of hepatocellular carcinoma cell lines by arresting cell cycle in S phase through up-regulation of p53, cyclin A, cyclin D3 and CDK6. Eriocitrin triggers apoptosis by activating mitochondria-involved intrinsic signaling pathway[1].

[1]. Wang Z, et al. Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle. Cancer Chemother Pharmacol. 2016 Dec;78(6):1143-1150.

Reseñas

Review for Eriocitrin

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Eriocitrin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.